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Abstract
Phlebitis from peripheral intravenous infusions is an important potential source of oncology patient morbidity. Important factors found to
determine phlebitis incidence include the kind of infusion and dwell time of intravenous cannula. Early studies showed incidence rates of
between 25-70% worldwide, and association with up to 10% of S. aureus bacteraemia. The introduction of the visual infusion phlebitis (VIP)
score tool for assessment of the early signs of phlebitis, along with prompt removal of peripheral intravenous cannulas, has been very
successful in reducing the incidence below the acceptable rate of 5%. However, achieving this goal depends on strict compliance with
guidelines for cannula insertion, documentation, and assessment using the VIP tool.
This study aimed to increase the use of VIP scoring tool to 100% on an oncology ward during a four to six month period in order to maximise
its utility in phlebitis prevention. Three plan-do-study-act (PDSA) cycles were carried out, during which two major interventions were
introduced. The first cycle aimed to improve junior doctors’ awareness of VIP scoring using presentations in induction meetings and posters.
The second cycle ensured that ready access to the VIP tool was provided in the form of bedside intentional rounding charts. Proportions of
intravenous cannulas with proper documentation and VIP assessment were measured before intervention and at nine subsequent bi-weekly
time points.
Pre-intervention, under 30% of cannulas were properly documented and assessed. This proportion rose to around 80% by the end of the
second PDSA cycle and achieved 100% by the end of the third cycle.
Problem
Peripheral venous catheters (PVCs), such as those routinely
inserted in busy oncology units all over the UK, can cause
infections ranging from local phlebitis to cellulitis to severe sepsis.
Data regarding the frequency of phlebitis or cellulitis related to
PVCs are not routinely collected. However, data concerning
patients with Staphylococcus aureus bacteraemia is collected by
infection control practitioners in our hospital, who investigate all
cases and assess relationship to PVCs. An incident of 11% is
estimated in the wider community of UK hospitals that are
considered to be the same as in Castle Hill Hospital (phlebitis
induced by cannulas is estimated between at 25-75% in different
studies).
The introduction of the visual infusion phlebitis (VIP) score tool for
assessment of early signs of phlebitis,and prompt removal of
peripheral intravenous cannulas, has been very successful in
reducing the incidence below the acceptable rate of 5%. However,
achieving this goal depends on strict compliance with guidelinesfor
cannula insertion, documentation and assessment using the VIP
tool.
Background
Healthcare workers insert peripheral intravenous (PIV) catheters
every day into the majority of patients who are admitted to an acute
care facility. It is estimated that 150 million PIV catheters are
inserted annually in the United States, with an increasing use of
medication therapy that is toxic to the veins. Early studies found
that 25%-70% of all the patients receiving PIV therapy developed
infusion-related phlebitis, defined as the inflammation of a vein, with
an acceptable rate of phlebitis at 5%.[5] Infusion-related phlebitis
may develop while the intravenous catheter is in situ and up to 96
hours after the intravenous catheter is removed.
Conclusive comparison of PIV phlebitis rates as measured by visual
assessment of the PIV site is dependent on the usage of a valid
and reliable phlebitis scale. The visual infusion phlebitis (VIP) scale,
a modified version of the original Maddox scale[15], was developed
to numerically rate phlebitis based on observable symptoms.[16]
This scale recommends a specific action for each numeric rating.
Standardized use of this scale can eliminate dwell time as the
predominant variable for changing peripheral PIV sites.
Baseline measurement
The visual infusion phlebitis documentation has been reviewed for
the 21 patients in the ward. A VIP was deemed incorrect when
either the date of the insertion, the name of the inserter, the number
of attempts, the date due to be reviewed, or the VIP score at
baseline was not correctly documented. Pre-intervention, under
30% of cannulas were properly documented and assessed, as you
can see in the run-chart.
  Page 1 of 2
© 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
See supplementary file: ds3668.pdf - “Pre- intervention
measurements”
Design
We understood that the main problem was that the doctors were
unaware of the VIP chart and/or where to find it in the trust
documents.
For that reason, we raised the awareness of all doctors in the team
by providing a teaching session in the morning handover and by
further explaining the place where the charts could be easily
accessed. We also placed a poster in the handover room in order to
act as a continuous reminder to all junior doctors.
Strategy
Three plan-do-study-act (PDSA) cycles were carried out, during
which two major interventions were introduced. The first was
designed to improve junior doctors’ awareness of VIP acoring using
presentations in induction meetings and posters (PDSA cycles 1
and 2). The second ensured that ready access to the VIP tool was
provided in the form of bedside intentional rounding charts (PDSA
cycle 3). Proportions of intravenous cannulas with proper
documentation and VIP assessment were measured before
intervention and at nine subsequent bi-weekly time points.
Results
After each PDSA cycle we checked what proportion of cannulas
had the correct VIP documentation (date, VIP score, name, flushed,
number of attempts, and date to be reviewed).
The proportion has increased from 28% (baseline) up to 85% after
six weeks, but then had fallen down to 60%. Another teaching
session was then organized for the new members of the team. The
proportion raised again up to 90% and subsequently fallen to 80%.
The proportion reached the target of 100% only when the PDSA
cycle 3 was introduced. This gave access to the VIP chart simply by
placing it at the end of the bed. The run-chart and table of results
are attached.
See supplementary file: ds3671.pdf - “QIP results table and
runcharts”
Lessons and limitations
The study was not without limitations. It was conducted with one
group of patients, primarily oncology patients, in only one unit of
one large hospital. This particular unit is mainly staffed by
experienced nurses, and inexperienced nurses generally find an
experienced nurse to start a PIV catheter if there is any question of
access. The number of changes in dressing per site, which could
affect mechanical phlebitis rates, was not recorded. However,
dressings are changed infrequently. Introducing a change is not
difficult when proper awareness is provided, and relatively small
interventions can often achieve relevant results.
Conclusion
Applying the intervention was an extremely positive action as it has
significantly improved VIP assessment. The number of incorrect
VIP evaluations decreased, meaning that patients were receiving
safer care, with the risk of phlebitis being safely reduced to less
than 5%.
What is clear is that in a busy environment such as a hospital,
workers need to be aware that the systems they work in are in need
of constant refinement to optimise working conditions and minimise
the potential for harm. The introduction of the VIP score at the end
of the bed has clearly had a significantly beneficial effect, but
should not make individuals complacent. There is always a need to
refine and optimise systems and this project has demonstrated just
that.
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